Dr. Jamshed Dalal

AREA(S) OF INTEREST:

Adult Interventional Cardiology, Cardiac Pharmacology

TREATMENTS/PROCEDURES OFFERED:

Angiography, Angioplasty, Pacemaker Implantation, Intravascular Ultrasound, FFR

FELLOWSHIPS:

• Life member Cardiological society of India
• Fellow of European Society of Cardiology
• Fellow of the Royal College of Physicians, London

• The Cardiology Society of India Prize for Distinction at D.M. Cardiology 1977.
• The “Young Research workers Award” by The British Cardiac Society, UK 1981.
• Jaycee award for “Outstanding Young Person”, Mumbai, 1985
• Awarded “Fellow of the Royal College of Physicians” London, 2016

Dr. Jamshed J Dalal is a rare triple Doctorate, having a Doctorate in Medicine, a Doctorate in Cardiology from Mumbai and a PhD from UK. He did his first coronary angiography in UK in 1978 and since then has done more than 20000 cases over 35 years. He also began the angiography program, available in only four hospitals in Mumbai in 1984 along with a handful of cardiologists.

Involved in the coronary angioplasty program since the invention of angioplasty procedure and is involved in teaching the procedure to doctors in India and China over the last 20 years.

As the Chief Cardiologist at the Holy Family Hospital in Bandra, set up the ICCU at the hospital.

In 1987 as the Honarary Cardiologist at the newly constructed Hinduja Hospital, Dr. Dalal set up the Cardiac Catheterization Lab at the hospital and started the coronary angiography and angioplasty procedures. He headed the department for eight years to establish it as a leading centre in India.

In 1995, he joined the still under construction Lilavati Hospital and helped along with others to set up the hospital along with the department of cardiology. Since inception to leaving the hospital in 2009, he remained the coordinator of the Cardiovascular Division and guided the Specialty to international levels.

In 1999, he helped along with two other colleagues to setup and establish the Wockhardt Heart Hospital now Fortis Hospital at Mulund, Mumbai once again creating a world class cardiology facility in the eastern suburbs. He then joined Kokilaben Hospitalwhen it started and helped establish the Centre for Cardiac Sciences.

KDAH Experience :

Dr. Jamshed Dalal is the Director of Centre for Cardiac Sciences at Kokilaben Hospital. He has performed thousands of Cardiac Cath procedures at Kokilaben Hospital since its inception.

Dr. Jamshed Dalal has numerous publications in International and National journals. He is a faculty on International Conferences and Workshops.He is fellow of the European Society of Cardiology.

Publications

• Trimetazidine in cardiovascular medicine, Mario Marzilli, Dragos Vineareanu, Gary Lopaschuk, Yundai Chen, Jamshed J Dalal et al; International Journal of Cardiology July 2019
• Advances and Innovation in Heart Failure: Textbook of Cardiology; 2019, Jamshed J Dalal; Chapter: Beta Blockers in Heart Failure
• Screening of PCSK9 in Familial Hypercholesterolemia Patients in India, Reddy LL, Ponde C, Rajani R, Pillai S, Dalal R, Vanjani C, Dalal JJ, Ashavaid TF; Poster: European Atherosclerotic Society, 2019
• Real World Azilsartan efficacy Assessment Study in Indian hypertensive patients (RAAS-India), Uday Jadhav, Jamshed Dalal; Abstract P107, Hypertension, 72(Suppl1), September 2018
• CSI position statement on management of heart failure in India, Santanu Guha, JJ Dalal and others; Indian Heart Journal, 2018; 705. S1-S72
• and others S-Amlodipine: An Isomer with Difference—Time to Shift from Racemic Amlodipine, Jamshed Dalal, J. C. Mohan, S. S. Iyengar, Jagdish Hiremath, Immaneni Sathyamurthy, Sandeep Bansal, Dhiman Kahali and Arup Dasbiswas; International Journal of Hypertension, Volume 2018, Article ID 8681792, 14 pages
• Therapeutic Experiencee of Ticagrelor in Indian Patients with ACS: A Prospective Observational study. TREASURE Study, JPS Sawhney, J Dalal, A Mullasari, S Bansal. D Kahali; Heart Asia 2018
• Study of the Clinical Characteristics and Management of Indian Outpatients of Chronic Heart Failure with Coexistent Diabetes Versus those without Diabetes (HF-DIAB): Rationale and Design. Meena Lopez, Jamshed Dalal, Sundeep Salvi and Jaideep Gogtay; J Cardiovasc Dis Diagn 2018, 6:3
• Aggressive management of atherosclerosis, Jamshed Dalal, Fouziya Malik, Aarti Digrajkar; CAD UPDATE 2018
• Textbook of Cardiology “Advances in Clinical Cardiovascular Imaging, Echocardiography & Interventions”, Editor:Jamshed J Dalal
• Textbook of Cardiology “Advances in Clinical Cardiovascular Imaging, Echocardiography & Interventions”, Jamshed J Dalal; βB Effect & Outcome evaluation by Echocardiography in Hypertension
• Cholesterol Management in Indians: Should We Treat the Targets or Treat the Risk?, Jamshed Dalal, JC Mohan, Arup Dasbiswas, Prafulla Kerkar, Shailendra Trivedi, Joy Thomas; Journal of Clinical and Diagnostic Research. 2018 Mar, Vol-12 (3): OE01-OE05
• Confronting system barriers for ST- elevation MI in low and middle income countries with a focus on India, Sameer Mehta, Christopher Granger, Cindy Lee Grines, Alice Jacobs,Timothy D. Henry, Ivan Rokos, Alexandra Lansky, Andreas Baumbach, Roberto Botelho , Alexandra Ferre, Isaac Yepes, Roopa Salwan, Jamshed Dalal, Jitendra Makkar, Neeraj Bhalla, Sundeep Mishra, Vinod Vijan, Shirish Hiremath; Indian Heart Journal 70 (2018) 185–190
• The Indian Consensus Guidance on Stroke Prevention in Atrial Fibrillation: A Practical View on the Use of Non-Vitamin K Antagonist Oral Anticoagulants, Jamshed Dalal, Abhay Bhave, Abraham Oomman, et al-SPAF Academy India experts; Journal of The Association of Physicians of India (sup); 1st March 2018 P6-26
• Cardioprotection in Diabetes, Jamshed J Dalal; Highlights, 69th Annual Conference of Cardiological Society of India; 2017, P- 78; (Editor Dr K Sarat Chandra)
• Cardiac Transplantation, Jamshed J Dalal, Nandkishore Kapadia; PI Text Book of Medicine, Edition 11, in press
• Cardiovascular Benefits of SGLT2 Inhibitors, Jamshed J Dalal; Cardiology Update 2017 (Cardiological Society of India), Chapter 16, P-125-133
• Bisoprolol: Is it superior in Cardiodiabetes?, Jamshed J Dalal; Cardiodiabetes Update (A Text book of Cardiology) 2017, chapter 67; P-450-454
• Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: A meta-analysis, Jamshed Dalal, Vijay Katekhaye, Rishi Jain; Indian Heart J; 2017, vol68, P 736-741
• ST2 In Heart failure, Jamshed J Dalal, Aarti Digrajkar; CAD Update 2017, Chapter
• Prevalence and control of cardiovascular risk factors in stable coronary artery outpatients in India compared with the rest of the world: An analysis from international CLARIFY registry, Upendra KauL, Subramaniam Natrajan , Jamshed Dalal , Ram Kirti Saran; Indian Heart Journal, online; (2017)
• Coronary stent infection- a grave, avoidable complication, Jamshed J. Dalal, Aarti Digrajkar, Meenal Hastak, Anvay Mulay, Vidyadhar Lad, Sunil Wani. IHJ online; 17-7-2017
• Confronting System Barriers for ST- elevation MI in Low and Middle Income Countries with a Focus on India
• Sameer Mehta, Christopher Granger, Cindy Lee Grines, Alice Jacobs, Timothy D Henry, Ivan Rokos, Alexandra Lansky, Andreas Baumbach, Roberto Botelho, Alexandra Ferre, Isaac Yepes, Roopa Salwan, Jamshed Dalal, Jitendra Makkar, Neeraj Bhalla, Sundeep Mishra, Vinod Vijan, Shirish Hiremath. IHJ accepted, 29-06-2017
• Contrast induced acute pancreatitis following coronary Intervention. Jamshed J Dalal, Aarti Digrajkar. Indian Heart journal online 2017
• Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure. Jamshed J Dalal, Sundeep Mishra; Indian Heart journal online 2017

Professional Memberships

• Cardiological Society of India
• Indian College of Interventional Cardiology
• Association of Consultants, Mumbai
• Indian Medical association
• Cardiovascular society of India
• Fellow of the European Society of Cardiology
• Fellow of the Royal College of Physicians

Dr. J. J. Dalal | Cardiology

A 92 year old man suffered from an acute myocardial infarction. He was hospitalized and thrombolized.In spite of full 15 day medical therapy, he continued to have symptoms, and option of angiography was suggested.However as he was 92 years old the patient and family were apprehensive about invasive procedures.We felt the patient had been fairly active prior to the episode and as he was remaining unstable we did his coronary angiogram. This revealed a severe stenosis in the LAD and after once again further long discussion with the relatives we went ahead and did angioplasty and stent implantation. He did remarkably well and became pain free and was infact discharged two days later.

This case shows that age alone should not be a consideration but the overall health of the patient and ofcourse the present clinical situation. The patients angio revealed a single lesion with the rest of the arteries being normal, suggesting that aging is not always associated with severity.

We have done several cases above 80 years but above 90 years is indeed rare atleast in India.However this case illustrates that whatever the age, relatively less invasive procedures like angioplasty can be done safely.